Chicago, given your personal interest if you want to look further wrt Apabetalone and heart failure you might start with the RVX news release of Jan 2, 2014 "Publications Confirm RVX-208 is a Unique Selective BET Bromodomain Antagonist". In the release it references a publication in Cell Journal regarding the potential of BET Inhibitors, including RVX-208, and their potential as therapeutics for heart failure.